0001209191-21-037821.txt : 20210603 0001209191-21-037821.hdr.sgml : 20210603 20210603174106 ACCESSION NUMBER: 0001209191-21-037821 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOLGER JOHN C CENTRAL INDEX KEY: 0001183863 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37894 FILM NUMBER: 21993819 MAIL ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE STREET 2: SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulgent Genetics, Inc. CENTRAL INDEX KEY: 0001674930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 812621304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 BUSINESS PHONE: 626-350-0537 MAIL ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 FORMER COMPANY: FORMER CONFORMED NAME: Fulgent Diagnostics, Inc. DATE OF NAME CHANGE: 20160517 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-01 0 0001674930 Fulgent Genetics, Inc. FLGT 0001183863 BOLGER JOHN C C/O FULGENT GENETICS, INC. 4978 SANTA ANITA AVE. TEMPLE CITY CA 91780 1 0 0 0 Common Stock 2021-06-01 4 M 0 313 3.93 A 2438 D Common Stock 2021-06-01 4 M 0 313 5.81 A 2751 D Common Stock 2021-06-01 4 M 0 1250 15.82 A 4001 D Common Stock 2021-06-01 4 S 0 1876 71.4102 D 2125 D Stock Option (Right to Buy) 3.93 2021-06-01 4 M 0 313 0.00 D 2028-05-18 Common Stock 313 1250 D Stock Option (Right to Buy) 5.81 2021-06-01 4 M 0 313 0.00 D 2029-05-30 Common Stock 313 2500 D Stock Option (Right to Buy) 15.82 2021-06-01 4 M 0 1250 0.00 D 2030-05-26 Common Stock 1250 3750 D The shares were sold in multiple transactions at prices ranging from $71.2781 to $71.4784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date. /s/ Paul Kim, as Attorney-in-fact 2021-06-03